Jimini Health Bags $17 Mn to Boost AI Behavioral Health Platform

At the heart of Jimini Health's offering is Sage, a clinically supervised AI therapist assistant available through a patient-facing platform.

Jimini Health is an innovative AI-enabled clinical health platform specifically designed for behavioral health providers. The company recently announced that it has successfully raised $17 million in seed funding, increasing its total funding to over $25 million.

Key investors in this latest funding round include M13, Town Hall Ventures, LionBird, Zetta Venture Partners, and OneMind.

At the heart of Jimini Health's offering is Sage, a clinically supervised AI therapist assistant available through a patient-facing platform.

This advanced behavioral health assistant facilitates patient interactions, allowing clinical teams to access conversations for better monitoring and support. Sage provides around-the-clock assistance between therapy sessions, offering useful exercises and guidance tailored to individual needs.

The newly acquired funding will primarily focus on enhancing technology and artificial intelligence capabilities, enabling Jimini Health to support a wider range of care settings and expand its partnerships with additional national behavioral health organizations.

Jimini Health was founded in 2024, backed by an initial $8 million in pre-seed funding from notable investors such as LionBird, Zetta Venture Partners, Arkitekt Ventures, SCB, PsyMed, and BoxGroup, among others.

In the broader context of digital mental healthcare, several other companies are also making significant strides. For instance, Spring Health, based in New York, offers AI-enabled digital mental health services, including navigation assistance for patients.

The company achieved a major milestone in 2024 by raising $100 million in a Series E funding round, which elevated its valuation to $3.3 billion. Prior to this, Spring Health secured $71 million in April 2023 and $190 million in Series C funding two years earlier.

Additionally, Brightside Health, a telemental health company located in San Francisco, focuses on treating individuals struggling with anxiety, mild to severe clinical depression, and other mood disorders through its Crisis Care psychiatry platform. In 2024, Brightside raised $33 million in Series C funding, bringing its total funding to $100 million.

This follows previous funding rounds that included $50 million in Series B funding in 2022 and $24 million in Series A funding in 2021.

The growth of these companies highlights the increasing demand for innovative mental health solutions, particularly those that leverage AI and technology to enhance patient care and accessibility.

Stay tuned for more such updates on Digital Health News